Tag: Cancer: Misc.
November 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2018. This roundup includes...
Teva Recalls Two Blood Pressure Medications
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
Recommended Therapies for Polycythemia Vera Underused
Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients
FDA Approves Vitrakvi for Cancers With Certain Genetic Trait
Drug targets solid tumors with NTRK gene fusion without a known acquired resistance mutation
AI-Based Smartphone App Can Help Cut Cancer Pain Severity
App can cut both severity of advanced cancer patients' reported pain and hospital admissions
Heart Disease Leading Cause of Death in Low-Income Counties
Greatest shift to cancer as leading cause of death seen in highest-income counties in United States
Coordinated Care Needed for Cancer Survivors, Caregivers
Efforts needed in implementing routine assessments of needs, facilitating personalized referrals
AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention
Second study shows no significant results for vitamin D supplementation versus placebo
Income, Lifestyle May Contribute to Disparity in Cancer Deaths
In addition to health care factors, issues outside of treatment may affect cancer death rates
Cancer Mortality Up for 2nd-, 3rd-Generation Latino Immigrants
Latino generation linked to cancer mortality risk after adjustment for education, lifestyle factors, illness
